**INTRODUCTION:** Fibrosis can enhance the exacerbation of lymphedema, which becomes obvious in Late Stage II -- Stage III lymphedema.^1--2^ However, whether the far-infrared radiation thermotherapy(FIRT) can cure lymphedema fibrosis is still lack of research. This research was to investigate the therapeutic effect of FIRT on tissue fibrosis in the treatment of Late Stage II to III lymphedema by evaluating clinical and laboratory evidence.

**METHODS:** Patients accepted only FIRT for 4 weeks (5 working days per week) for a total of 20 sessions. The treatment session duration was 2 hours and a stable machine temperature of 42°C was maintained throughout treatments. Clinical evaluation and laboratory evaluation were conducted to assess the enrolled patients before and after FIRT. Clinical outcome measures included circumference of affected extremity, skin elasticity, ultrasound,patients'subjective assessment and quality of life. Laboratory outcome measures included serum and local lymphedema tissue fluid concentrations of fibrosis associated cytokines TGF-β1, IL-1β, IL-4, IL-18 and Caspase-1.

**RESULTS:** Between 2015 and 2016, clinical evaluation of 64 patients with Late Stage II to III lymphedema was conducted before and after FIRT. From this group, 12 cases (18.75%) underwent simultaneous laboratory evaluation. Circumferences of affected extremities improved significantly following treatment(p=0.000). Skin elasticity parameters R0, R2, R5, and Q0 for the affected extremity improved significantly following treatment (p=0.001, 0.031, 0.005 and 0.001 respectively). Ultrasound investigation showed reduced fibre and dense material in the affected tissue (increased grey level 6.322 ± 7.624%, p=0.000). Patients reported a subjective improvement of their symptoms: decreased tightness, heaviness, solidity, pain, discomfort and numbness (p=0.000, 0.000, 0.000, 0.000, 0.000 and 0.032 respectively), and improved quality of life (p=0.000). Laboratory results revealed a significant decrease in local tissue fluid concentrations of TGF-β1 (p=0.041) and IL-18 (p=0.049) after course completion.

**CONCLUSION:** FIRT provides an effective treatment for lymphedema tissue fibrosis; it reduces the concentration of fibrosis cytokines in local lymphedema tissues. Consequently, this treatment can reduce the density of fibrosed tissue in the affected extremity, increase skin elasticity, significantly improve clinical symptoms and improve the quality of life of patients.
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